PAG
VIVO

Private Advisor Group’s Meridian Bioscience Inc VIVO Stock Holding History

Private Advisor Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,375
Closed -$32K – 3714
2020
Q2 		$32K Buy
+1,375
New +$19.9K ﹤0.01% 2330

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Private Advisor Group's VIVO Position: Q3 2020 in Review

Private Advisor Group sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 1,375 shares — an estimated $32K sold.

Private Advisor Group first reported a position in VIVO in Q2 2020 and held it in 1 quarter. The position peaked at $32K in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Private Advisor Group reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,375 Meridian Bioscience Inc shares in Q3 2020, an estimated $32K.
  • Private Advisor Group first reported a position in Meridian Bioscience Inc in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Meridian Bioscience Inc position peaked at $32K in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.